BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7549893)

  • 1. Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?
    Kessinger A
    Stem Cells; 1995 Jul; 13(4):351-4. PubMed ID: 7549893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants.
    Henon PR; Liang H; Beck-Wirth G; Eisenmann JC; Lepers M; Wunder E; Kandel G
    Bone Marrow Transplant; 1992 Apr; 9(4):285-91. PubMed ID: 1376185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
    Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of stem cell transplantation and immunotherapy: future potential.
    Talmadge JE
    In Vivo; 1994; 8(5):675-90. PubMed ID: 7727713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
    Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
    Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
    Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
    Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
    di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
    Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell transplantation as an alternative to bone marrow transplantation: an overview.
    Janakiraman N
    Henry Ford Hosp Med J; 1991; 39(2):103-7. PubMed ID: 1679756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.